Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- NEPAD: Ethiopian Nardos Bekele-Thomas reappointed as Director General
- Transparency International Ranking 2025: Stability of Benin’s score raises questions and reflects a slow perception of ongoing reforms
- AI Summit in New Delhi: Africa at the heart of the France-India convergence
- Mauritania: Former Wali Zakaria Thiam Opens His Expertise Firm
- Congo announces successful partial buyback of its 2032 bond
- Ugandan senior officials pursued by entrepreneur Vasundhara Oswal for arbitrary detention
- Morocco, acquisition of BMCI: JP Morgan, EY, KPMG and Bain & Company mobilized for the operation
- Vista Group Holding finalizes the acquisition of 99.99% of Saham Assurances Niger, now Vista Assurances Niger
